These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 14632587)
1. Modafinil for remitted bipolar depression with hypersomnia. Fernandes PP; Petty F Ann Pharmacother; 2003 Dec; 37(12):1807-9. PubMed ID: 14632587 [TBL] [Abstract][Full Text] [Related]
2. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135 [TBL] [Abstract][Full Text] [Related]
3. Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice. Nasr S; Wendt B; Steiner K J Affect Disord; 2006 Oct; 95(1-3):111-4. PubMed ID: 16737742 [TBL] [Abstract][Full Text] [Related]
4. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899 [TBL] [Abstract][Full Text] [Related]
5. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Jones DE; Newton JL Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003 [TBL] [Abstract][Full Text] [Related]
6. Modafinil use in patients with a primary psychiatric illness. Black W; Hoey P; Mayze T Aust N Z J Psychiatry; 2010 Jun; 44(6):583-4. PubMed ID: 20482418 [No Abstract] [Full Text] [Related]
7. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
8. Modafinil: a second look. Confirmed efficacy in narcolepsy. Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564 [TBL] [Abstract][Full Text] [Related]
9. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016 [TBL] [Abstract][Full Text] [Related]
10. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. Vaishnavi S; Gadde K; Alamy S; Zhang W; Connor K; Davidson JR J Clin Psychopharmacol; 2006 Aug; 26(4):373-8. PubMed ID: 16855454 [TBL] [Abstract][Full Text] [Related]
11. Classifying mood disorders by age-at-onset instead of polarity. Benazzi F Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784 [TBL] [Abstract][Full Text] [Related]
12. Modafinil: new indication. For a minority of patients with sleep apnoea. Prescrire Int; 2007 Jun; 16(89):102-3. PubMed ID: 17582924 [TBL] [Abstract][Full Text] [Related]
13. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study. Lundt L J Affect Disord; 2004 Aug; 81(2):173-8. PubMed ID: 15306145 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772 [TBL] [Abstract][Full Text] [Related]
15. A prospective trial of modafinil as an adjunctive treatment of major depression. DeBattista C; Lembke A; Solvason HB; Ghebremichael R; Poirier J J Clin Psychopharmacol; 2004 Feb; 24(1):87-90. PubMed ID: 14709953 [TBL] [Abstract][Full Text] [Related]
16. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091 [TBL] [Abstract][Full Text] [Related]
17. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129 [TBL] [Abstract][Full Text] [Related]
18. Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report. Clemons WE; Makela E; Young J Sleep Med; 2004 Sep; 5(5):509-11. PubMed ID: 15341899 [TBL] [Abstract][Full Text] [Related]
19. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S; J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184 [TBL] [Abstract][Full Text] [Related]
20. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression. Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A J Affect Disord; 2005 Feb; 84(2-3):141-7. PubMed ID: 15708411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]